This is from May 30th 2018 BDD Pharma today ann
Post# of 72440
BDD Pharma today announced that it has signed an agreement to license OralogiK™, its timed drug delivery technology, to Novartis Pharma AG for the development of a new product containing an undisclosed compound. The agreement includes an upfront payment, milestones and future royalties.
We still don't know what that undisclosed compound is. Can it be????